UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 11-K

(Mark One)

			ý			ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

OR

 

			¨			TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-37702

THE RETIREMENT AND SAVINGS PLAN FOR

AMGEN MANUFACTURING, LIMITED

State Road 31, Kilometer 24.6, Juncos, Puerto Rico 00777

(Full title and address of the plan)

AMGEN INC.

(Name of issuer of the securities held)

 

One Amgen Center Drive,						91320-1799
Thousand Oaks, California						(Zip Code)
(Address of principal executive offices)

---

The Retirement and Savings Plan for

Amgen Manufacturing, Limited

Audited Financial Statements

and Supplemental Schedule

Year Ended December 31, 2022

Contents

 

Report of Independent Registered Public Accounting Firm			1
Audited Financial Statements:
Statements of Net Assets Available for Benefits at December 31, 2022 and 2021			2
Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 2022			3
Notes to Financial Statements			4
Supplemental Schedule:
Schedule of Assets (Held at End of Year)			10
Index to Exhibit			18
Signatures			19

---

Report of Independent Registered Public Accounting Firm

To the Plan Participants and the Plan Administrator of The Retirement and Savings Plan for Amgen Manufacturing, Limited

Opinion on the Financial Statements

We have audited the accompanying statements of net assets available for benefits of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) as of December 31, 2022 and 2021, and the related statement of changes in net assets available for benefits for the year ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2022 and 2021, and the changes in its net assets available for benefits for the year ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Supplemental Schedule Required by ERISA

The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2022, (referred to as the “supplemental schedule”), has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.

/s/ ERNST & YOUNG LLP

We have served as the Plan’s auditor since 1992.

Los Angeles, California

June 14, 2023

1

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Statements of Net Assets Available for Benefits

						December 31,
						2022						2021
Assets
Investments at fair value						$	595,003,942					$	669,938,625
Notes receivable from participants						16,068,774						15,668,200
Other – principally due from broker						395,402						469,779
Total assets						611,468,118						686,076,604
Liabilities
Other – principally due to broker						462,064						404,824
Total liabilities						462,064						404,824
Net assets available for benefits						$	611,006,054					$	685,671,780

See accompanying notes.

2

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Statement of Changes in Net Assets Available for Benefits

						Year Ended December 31,
						2022
Additions to (deductions from) net assets:
Employer contributions						$	20,160,074
Participant contributions						19,306,766
Rollover contributions						521,004
Interest and dividend income						5,053,185
Net realized/unrealized losses						(83,780,824)
Interest income on notes receivable from participants						682,956
Benefits paid						(35,673,066)
Investment and administrative fees						(935,821)
Net decrease						(74,665,726)
Net assets available for benefits at beginning of year						685,671,780
Net assets available for benefits at end of year						$	611,006,054

See accompanying notes.

3

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements

December 31, 2022

1. Description of the Plan

The following description of The Retirement and Savings Plan for Amgen Manufacturing, Limited (the Plan) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

General

The Plan was established effective May 1, 1992, and was amended and restated effective January 1, 2017, and subsequently amended, with the most recent amendment adopted on December 13, 2021. The Plan is a defined contribution plan covering substantially all Puerto Rico resident employees of Amgen Manufacturing, Limited (the Company), a wholly owned subsidiary of Amgen Inc. (Amgen). The Plan is intended to qualify under Section 1081.01 of the Puerto Rico Internal Revenue Code of 2011, as amended (the PR Code) (see Note 4, Income Tax Status) and section 407(d)(3)(A) of the Employee Retirement Income Security Act of 1974 (ERISA).

Contributions

Subject to certain limitations (as defined in the Plan), participants may elect to contribute up to 30% of their eligible compensation in pre-tax contributions and after-tax contributions or a combination of these types of contributions (together, Individual Contributions). A participant’s pre-tax contributions are subject to the PR Code and Plan limitations and could not exceed $15,000 in 2022. Participants may elect to contribute after-tax contributions beginning January 1 of the year following the year the participant was hired. Participant after-tax contributions are subject to the PR Code and Plan limitations and could not exceed $1,500 in 2022. Unless an employee has voluntarily enrolled in the Plan or has declined to participate in the Plan within the first 30 days of employment, all newly eligible participants are automatically enrolled in the Plan, and contributions equal to 5% of their eligible compensation are withheld and contributed to the Plan as pre-tax contributions; such contributions are automatically increased by 1% per year until their contributions reach 10% of their eligible compensation. Participants may elect to adjust, cease or resume their Individual Contributions at any time.

Participants who are at least age 50 by the close of the Plan year may also elect to make certain additional pre-tax Individual Contributions, referred to as catch-up contributions, that are subject to the PR Code and Plan limitations and could not exceed $1,500 in 2022. Participants may also contribute pre-tax and after-tax amounts representing distributions from certain other retirement plans qualified in Puerto Rico, referred to as rollover contributions (as defined in the Plan).

Each pay period, the Company makes a non-elective contribution for all eligible participants, whether or not they have elected to make Individual Contributions to the Plan, equal to 4% of each participant’s eligible compensation up to a maximum of $12,200 in 2022 (Core Contributions). In addition, the Company makes a contribution equal to amounts contributed by the participant as pre-tax contributions, including catch-up contributions, of up to 5% of eligible compensation (Matching Contributions). Matching Contributions could not exceed $15,000 in 2022.

Participants select the investments in which their Individual Contributions, including their Core Contributions and Matching Contributions (collectively, Company Contributions), are to be invested, electing among various alternatives, including Amgen common stock (Amgen stock). Participants may direct a maximum of 20% of contributions to be invested in Amgen stock. In addition, participants may transfer amounts among the investment options at any time, subject to certain limitations. Notwithstanding the foregoing, if 20% or more of the value of a participant’s Plan account is invested in Amgen stock, the Plan document provides that no transfers from other investment options can be made to invest in Amgen stock.

The accounts of participants who had never made an investment election are allocated to investments under a qualified default investment alternative, which is intended to be compliant with ERISA regulations. At any time, participants may elect to alter the investments in their accounts made under a qualified default investment alternative.

4

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

Vesting

Participants are immediately vested with respect to their Individual Contributions and Matching Contributions and earnings and losses (hereafter referred to as earnings) thereon. Participants hired prior to January 1, 2020, are also immediately vested with respect to their Core Contributions and earnings thereon. Participants hired on or after January 1, 2020, vest in full with respect to their Core Contributions and earnings thereon after three years of service, as defined by the terms of the Plan, or upon reaching age 65 while employed by the Company, if earlier. If a participant ceases to be an employee before fully vesting in their account, the non-vested portion of the participant’s account will be treated as a forfeiture, as defined by the terms of the Plan, on the earlier of (a) the date the participant incurs a five-year break in service, as defined by the terms of the Plan or, (b) the date the participant receives a distribution of the entire vested portion of their account.

Participant Accounts

Each participant’s account is credited with: (a) the participant’s Individual Contributions; (b) an allocation of Company Contributions; and (c) earnings. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account.

Plan Investments

Plan participants can invest in seven different asset classes as well as Amgen stock or can actively manage their account under a self-directed brokerage arrangement in which a wider array of investment options are available. The value of an investment in an asset class is determined by its underlying investment vehicles, which may include one or more of the following: mutual funds, collective trust funds and portfolios, which are separately managed exclusively for the benefit of Plan participants and their beneficiaries (separately managed portfolios). The separately managed portfolios are composed primarily of investments in publicly traded common and preferred stocks. The asset classes are designed to provide participants with choices among a variety of investment objectives.

Payments of Benefits

Subject to Plan limitations, upon termination of employment, including termination due to disability (as defined in the Plan) or retirement, a participant may elect to receive a full or partial distribution of his or her account balance in: (a) a single payment in cash; (b) a single distribution in full shares of Amgen stock (with any fractional shares paid in cash); (c) a single distribution paid in a combination of cash and full shares of Amgen stock; or (d) a rollover distribution to an eligible retirement plan.

Participants may also elect to maintain their account balance in the Plan subsequent to termination of employment, provided that their account balance is greater than $1,000.

If a participant dies before receiving the value of his or her account balance, the participant’s beneficiary may elect to receive the distribution of remaining funds from among the alternatives described above, subject to certain Plan limitations.

No withdrawals may be made from the Plan while a participant continues to be employed by the Company except in certain circumstances including, but not limited to, financial hardship, disability and attainment of age 59 1/2.

Notes Receivable from Participants

Subject to certain restrictions, a participant can have up to two loans outstanding at any one time from his or her Plan account with a combined maximum loan amount that may not exceed the lesser of: (a) 50% of the participant’s account balance or (b) $50,000 less certain adjustments, as applicable (as defined in the Plan). A participant’s loan is secured by his or her Plan account balance. Loans bear interest at fixed rates which, until changed by the Company, are based on the prime rate plus one percentage point as published in The Wall Street Journal, determined as of the last day of the calendar quarter preceding origination or such other rate as may be required by law. Loans are generally payable in installments over periods ranging from one to five years, unless the loan is used to acquire a principal residence for which the term of the loan may be up to 20 years. Principal and interest payments are allocated to the participant’s account.

5

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

Plan Termination

Although it has not expressed any intent to do so, the Company has the right under the Plan to terminate the Plan subject to the provisions of ERISA. Upon termination, participants would become fully vested in Core Contributions and receive distributions of their account balances.

Trustee and Custodians

Banco Popular de Puerto Rico is the Plan’s trustee. Bank of America, N.A. is the Plan’s custodian with respect to the self-directed brokerage arrangement and the Amgen common stock fund. Northern Trust Company, NA (Northern) is the Plan’s custodian with respect to the asset classes.

2. Summary of Significant Accounting Policies

Basis of Accounting

The accompanying financial statements are prepared on the accrual basis of accounting. Benefits to participants are recorded when paid.

Fair Value Measurement

The investments of the Plan are reported at fair value. Fair value is generally defined as the price that would be received to sell an asset or paid to transfer a liability (the exit price) in an orderly transaction between market participants at the measurement date (see Note 3, Fair Value Measurements).

Investment Income and Losses

Dividend income is recognized on the ex-dividend date, and interest income is recorded on an accrual basis. Unrealized gains and losses on investments are measured by the change in the difference between the fair value and cost of the securities held at the beginning of the year (or date purchased if acquired during the Plan year) and the end of the year. Realized gains and losses from security transactions are recorded based on the weighted-average cost of securities sold.

Notes Receivable from Participants

Notes receivable from participants are carried at their unpaid balance plus accrued but unpaid interest, as applicable.

Due from/to Brokers

Purchases and sales of investments are recorded on a trade-date basis. Amounts due from and due to brokers arise from unsettled sale and purchase transactions, respectively.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Risks and Uncertainties

The Plan provides for investment options representing varied combinations of equities (including Amgen stock), fixed income, and other investments. Investments, in general, particularly in securities, are exposed to various risks, such as interest rate, inflation, market and credit risks, among others. Market risk includes global events which could impact the value of investments, including securities, such as a pandemic or international conflict. Due to the level of risk associated with certain investments, including securities, it is at least reasonably possible that changes in the values of the Plan’s investments, including securities, will occur in the near term and that such changes could materially affect participant account balances and the amounts reported in the Plan’s financial statements.

6

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

3. Fair Value Measurements

The Plan uses various valuation approaches in determining the fair value of investments within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the investment based on market data obtained from independent sources. Unobservable inputs are inputs that reflect assumptions about the inputs that market participants would use in pricing the investment and are developed based on the best information available in the circumstances. The fair value hierarchy is divided into three levels based on the source of inputs as follows:

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical investments that the Plan has the ability to access;

Level 2 – Valuations for which all significant inputs are observable, either directly or indirectly, other than Level 1 inputs;

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary among the various types of investments. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used for measuring fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level of input used that is significant to the overall fair value measurement.

The following fair value hierarchy tables present information about each major class/category of the Plan’s investments measured at fair value:

						Fair value measurements at December 31, 2022, using
						Quoted prices in active markets for identical assets (Level 1)						Significant other observable inputs (Level 2)						Significant unobservable inputs (Level 3)						Total
Amgen stock						$	103,662,409					$	—					$	—					$	103,662,409
Cash and cash equivalents						200,285						—						—						200,285
Collective trust funds						—						372,729,128						—						372,729,128
Common and preferred stock						101,755,093						—						—						101,755,093
Mutual funds						8,345,597						—						—						8,345,597
Self-directed brokerage accounts						8,311,430						—						—						8,311,430
Total investments at fair value						$	222,274,814					$	372,729,128					$	—					$	595,003,942

 

7

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

						Fair value measurements at December 31, 2021, using
						Quoted prices in  active markets  for identical assets (Level 1)						Significant other observable inputs (Level 2)						Significant unobservable inputs (Level 3)						Total
Amgen stock						$	92,566,483					$	—					$	—					$	92,566,483
Cash and cash equivalents						4,231,214						—						—						4,231,214
Collective trust funds						—						410,998,784						—						410,998,784
Common and preferred stocks						143,456,396						—						—						143,456,396
Mutual funds						7,440,054						—						—						7,440,054
Self-directed brokerage accounts						11,245,694						—						—						11,245,694
Total investments at fair value						$	258,939,841					$	410,998,784					$	—					$	669,938,625

The fair values of substantially all common stocks (including Amgen stock), preferred stocks, mutual funds and underlying investments of self-directed brokerage accounts are valued using quoted market prices in active markets with no valuation adjustment.

Collective trust funds represent interests in pooled investment vehicles designed typically for collective investment of employee benefit trusts. The fair values of these investments are determined by reference to the net asset value per unit provided by the fund managers as the basis for current transactions.

4. Income Tax Status

The Plan received an opinion letter from the Puerto Rico Treasury Department (PRTD) dated February 26, 2018, with an effective date of January 1, 2017, stating that the Plan meets the requirements of Section 1081.01 of the PR Code and the regulations thereunder, and, therefore the related trust forming part of the Plan is exempt from taxation. Subsequently, six amendments were made to the Plan, and the Plan received letters from the PRTD stating the PRTD has no objection to the first four of these amendments. The Company has submitted the fifth and sixth amendments to the PRTD requesting an opinion that the Plan remains in compliance with the PR Code and regulations thereunder. Once qualified, the Plan is required to operate in conformity with the PR Code to maintain its qualification.

For taxable year 2022, the Company believes the Plan satisfied, and operated in compliance with, the applicable requirements of the PR Code and therefore believes that the Plan, as amended, is qualified and the related trust is tax exempt. The Company has indicated that it currently intends to continue to take the necessary steps, if any, to maintain the Plan’s compliance with the applicable requirements of the PR Code.

5. Party-in-Interest Transactions

Parties-in-interest are certain entities defined under Department of Labor regulations, including Amgen, and other parties that provide services to the Plan, such as the trustees, custodians and investment managers. The Plan pays the custodians certain administrative and investment management fees, and the Company pays certain administrative fees on behalf of the Plan. The Plan invests in collective trust funds managed by Northern, certain of the Plan’s investment managers and other third parties and may invest in securities of entities that are parties-in-interest. The Plan also invests in shares of common stock of Amgen and receives dividends on those shares. Notes receivable from participants are also considered party-in-interest transactions.

8

---

The Retirement and Savings Plan for Amgen Manufacturing, Limited

Notes to Financial Statements (continued)

6. Reconciliation of Financial Statements to the Form 5500

The reconciliation of net assets available for benefits per the financial statements to the Form 5500 consisted of the following:

						December 31,
						2022						2021
Net assets available for benefits per the financial statements						$	611,006,054					$	685,671,780
Deemed loans						(753,247)						(672,422)
Net assets per the Form 5500						$	610,252,807					$	684,999,358

The following is a reconciliation of expenses per the financial statements to the Form 5500:

						Year Ended December 31, 2022
Benefits paid						$	(35,673,066)
Investment and administrative fees						(935,821)
Total expenses per the financial statements						(36,608,887)
Deemed loans at December 31, 2021						672,422
Deemed loans at December 31, 2022						(753,247)
Total expenses per the Form 5500						$	(36,689,712)

9

---

Supplemental Schedule

The Retirement and Savings Plan for Amgen Manufacturing, Limited

EIN: 98-0210484 Plan: #001

As of December 31, 2022

Schedule H, line 4i – Schedule of Assets (Held at End of Year)

Identity of Issue

Description of Investment

Current Value

Amgen Stock*

Employer Securities 394,694 shares

103,662,409

$

103,662,409

Capital Preservation Asset Class:

Galliard Stable Return Fund W*

Collective Trust Fund 1,242,855 units

75,788,056

NT Collective Short Term Investment Fund*

Collective Trust Fund 4,223,182 units

4,223,182

Total Capital Preservation Asset Class

80,011,238

Fixed Income Active Asset Class:

MetLife Core Plus Collective Fund*

Collective Trust Fund 918,963 units

8,546,360

Wellington Core Bond Plus Portfolio Collective Investment Trust II*

Collective Trust Fund 772,168 units

8,524,740

Schroder Global Strategic Bond Trust Class W*

Collective Trust Fund 276,029 units

2,718,888

Putnam Absolute Return Fixed Income Fund*

Collective Trust Fund 36,931 units

2,712,610

Northern Trust Global Investments Collective Daily Aggregate Bond Index Fund - Non Lending*

Collective Trust Fund 792,880 units

1,637,983

Total Fixed Income Active Asset Class

24,140,581

Fixed Income Index Asset Class:

Northern Trust Global Investments Collective Daily Aggregate Bond Index Fund - Non Lending*

Collective Trust Fund 792,880 units

111,478,898

Total Fixed Income Index Asset Class

111,478,898

U.S. Equity Active Asset Class:

NT Collective Russell 3000 Index Fund / Non Lending*

Collective Trust Fund 79,450 units

4,729,549

Visa Inc. Class A

Common and Preferred Stock 13,243 shares

2,751,366

NT Collective Short Term Investment Fund*

Collective Trust Fund 2,706,179 units

2,706,179

Amazon Inc.

Common and Preferred Stock 29,672 shares

2,492,448

Microsoft Corporation

Common and Preferred Stock 9,195 shares

2,205,145

General Electric

Common and Preferred Stock 20,569 shares

1,723,477

TransDigm Group Inc.

Common and Preferred Stock 1,973 shares

1,242,299

Intuit Inc.

Common and Preferred Stock 3,146 shares

1,224,486

Netflix, Inc.

Common and Preferred Stock 3,933 shares

1,159,763

Dexcom Inc.

Common and Preferred Stock 8,826 shares

999,456

Ball Corporation

Common and Preferred Stock 19,227 shares

983,269

ServiceNow Inc.

Common and Preferred Stock 2,355 shares

914,376

The Carlyle Group Inc.

Common and Preferred Stock 30,274 shares

903,376

Heico Corporation Class A

Common and Preferred Stock 7,390 shares

885,692

Skechers USA Inc. Class A

Common and Preferred Stock 20,880 shares

875,916

UnitedHealth Group Inc.

Common and Preferred Stock 1,638 shares

868,435

Citigroup Inc.

Common and Preferred Stock 18,779 shares

849,374

Dow Inc.

Common and Preferred Stock 16,518 shares

832,342

10

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

Alphabet Inc.

Common and Preferred Stock 9,348 shares

829,448

Danaher Corporation

Common and Preferred Stock 3,072 shares

815,370

Skyworks Solutions Inc

Common and Preferred Stock 8,841 shares

805,680

Jones Lang LaSalle Inc.

Common and Preferred Stock 4,967 shares

791,591

SS&C Technologies Holdings Inc.

Common and Preferred Stock 14,665 shares

763,460

Wells Fargo & Company*

Common and Preferred Stock 18,435 shares

761,181

Lear Corporation

Common and Preferred Stock 6,118 shares

758,754

KKR & Company Inc. Class A

Common and Preferred Stock 16,245 shares

754,093

Workday Inc. Class A

Common and Preferred Stock 4,494 shares

751,981

Mastercard Inc. Class A

Common and Preferred Stock 2,132 shares

741,360

Qorvo, Inc.

Common and Preferred Stock 8,135 shares

737,356

MSCI Inc.

Common and Preferred Stock 1,583 shares

736,364

CoStar Group Inc.

Common and Preferred Stock 9,424 shares

728,287

Alphabet Inc. Class C

Common and Preferred Stock 8,085 shares

717,382

Yum! Brands Inc.

Common and Preferred Stock 5,506 shares

705,208

S&P Global Inc

Common and Preferred Stock 2,085 shares

698,350

Equinix Inc.

Common and Preferred Stock 1,024 shares

670,751

Thermo Fisher Corporation

Common and Preferred Stock 1,216 shares

669,639

Salesforce.com Inc.

Common and Preferred Stock 4,930 shares

653,669

Henry Schein Inc.

Common and Preferred Stock 8,184 shares

653,656

Applied Materials Inc.

Common and Preferred Stock 6,687 shares

651,180

Ecolab, Inc.

Common and Preferred Stock 4,454 shares

648,324

Salesforce.com Inc.

Common and Preferred Stock 4,872 shares

645,978

Costar Group Inc.

Common and Preferred Stock 8,356 shares

645,752

Merit Medical Systems Inc.

Common and Preferred Stock 9,044 shares

638,687

Clean Harbors Inc.

Common and Preferred Stock 5,558 shares

634,279

Block, Inc.

Common and Preferred Stock 10,093 shares

634,244

Cognizant Technology Solutions Corporation Class A

Common and Preferred Stock 10,999 shares

629,033

Match Group Inc.

Common and Preferred Stock 14,797 shares

613,928

Fresenius Medical Care

Common and Preferred Stock 37,471 shares

612,276

QuidelOrtho Corporation

Common and Preferred Stock 7,007 shares

600,290

STERIS plc

Common and Preferred Stock 3,225 shares

595,625

Wabtec Corporation

Common and Preferred Stock 5,920 shares

590,875

Newell Brands Inc.

Common and Preferred Stock 45,083 shares

589,686

Edison International

Common and Preferred Stock 9,266 shares

589,503

Autodesk Inc.

Common and Preferred Stock 3,119 shares

582,848

Iqvia Holdings Inc.

Common and Preferred Stock 2,830 shares

579,839

Waste Connections Inc.

Common and Preferred Stock 4,368 shares

579,022

Regeneron Pharmaceuticals, Inc.

Common and Preferred Stock 798 shares

575,749

Intuitive Surgical, Inc.

Common and Preferred Stock 2,150 shares

570,503

MetLife Inc.*

Common and Preferred Stock 7,881 shares

570,348

Sherwin-Williams Company

Common and Preferred Stock 2,353 shares

558,437

Halozyme Therapeutics Inc.

Common and Preferred Stock 9,782 shares

556,596

Capital One Financial Corporation

Common and Preferred Stock 5,899 shares

548,371

Equitable Holdings Inc.

Common and Preferred Stock 18,950 shares

543,865

Ares Management Corporation

Common and Preferred Stock 7,846 shares

536,980

FMC Corporation

Common and Preferred Stock 4,172 shares

520,666

CBRE Group Inc. Class A

Common and Preferred Stock 6,732 shares

518,095

Anthem Inc.

Common and Preferred Stock 1,009 shares

517,587

Ritchie Bros Auctioneers Inc.

Common and Preferred Stock 8,945 shares

517,289

Synopsys Inc.

Common and Preferred Stock 1,610 shares

514,057

11

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

NICE Limited

Common and Preferred Stock 2,649 shares

509,403

Voya Financial Inc.

Common and Preferred Stock 8,159 shares

501,697

Aon PLC

Common and Preferred Stock 1,671 shares

501,534

Lam Research Corporation

Common and Preferred Stock 1,168 shares

490,910

American Express Company

Common and Preferred Stock 3,322 shares

490,826

Ametek Inc.

Common and Preferred Stock 3,510 shares

490,417

Starbucks Corporation

Common and Preferred Stock 4,919 shares

487,965

Charles River Laboratories International Inc.

Common and Preferred Stock 2,234 shares

486,789

FleetCor Technologies Inc.

Common and Preferred Stock 2,630 shares

483,078

JP Morgan Chase & Company

Common and Preferred Stock 3,600 shares

482,760

Booking Holdings Inc.

Common and Preferred Stock 233 shares

469,560

Sensata Technologies BV Holding

Common and Preferred Stock 11,485 shares

463,764

Gildan Activewear Inc.

Common and Preferred Stock 16,718 shares

458,073

Adobe Systems Inc.

Common and Preferred Stock 1,335 shares

449,268

Amdocs Limited

Common and Preferred Stock 4,903 shares

445,683

Shopify Inc

Common and Preferred Stock 12,798 shares

444,219

American International Group Inc.

Common and Preferred Stock 6,919 shares

437,558

Bristol Myers Squibb

Common and Preferred Stock 6,035 shares

434,218

Amphenol Corporation Class A

Common and Preferred Stock 5,490 shares

418,009

Frontdoor Inc.

Common and Preferred Stock 19,642 shares

408,554

Uber Technologies Inc.

Common and Preferred Stock 16,491 shares

407,822

Alight Inc. Class A

Common and Preferred Stock 48,658 shares

406,781

Warner Music Group Corporation Class A

Common and Preferred Stock 11,572 shares

405,251

J2 Global Inc.

Common and Preferred Stock 5,122 shares

405,150

Atlassian Corporation

Common and Preferred Stock 3,117 shares

401,096

Axis Capital Holdings Limited

Common and Preferred Stock 7,397 shares

400,695

Dollar General Corporation

Common and Preferred Stock 1,619 shares

398,679

BWX Technologies Inc.

Common and Preferred Stock 6,825 shares

396,396

IDEX Corporation

Common and Preferred Stock 1,698 shares

387,704

NOV Inc.

Common and Preferred Stock 18,554 shares

387,593

Hewlett Packard Enterprise Company

Common and Preferred Stock 24,135 shares

385,195

Euronet Worldwide Inc.

Common and Preferred Stock 4,080 shares

385,070

Bank of America Corporation*

Common and Preferred Stock 11,404 shares

377,700

Align Technology Inc.

Common and Preferred Stock 1,789 shares

377,300

Snowflake Inc. Class A

Common and Preferred Stock 2,608 shares

374,352

Catalent Inc.

Common and Preferred Stock 8,225 shares

370,207

Floor & Decor Holdings Inc.

Common and Preferred Stock 5,315 shares

370,083

Lam Resh Corporation

Common and Preferred Stock 877 shares

368,603

LKQ Corporation

Common and Preferred Stock 6,889 shares

367,941

Entegris Inc.

Common and Preferred Stock 5,570 shares

365,336

UGI Corporation

Common and Preferred Stock 9,829 shares

364,361

PVH Corporation

Common and Preferred Stock 5,103 shares

360,221

Abbott Laboratories

Common and Preferred Stock 3,137 shares

344,411

Halliburton Company

Common and Preferred Stock 8,619 shares

339,158

Ingredion Inc.

Common and Preferred Stock 3,439 shares

336,781

HealthEquity Inc.

Common and Preferred Stock 5,428 shares

334,582

Huntington Bancshares Inc.

Common and Preferred Stock 23,452 shares

330,673

Acadia Healthcare Company Inc.

Common and Preferred Stock 3,899 shares

320,966

Cloudflare Inc.

Common and Preferred Stock 7,025 shares

317,600

Churchill Downs Inc.

Common and Preferred Stock 1,465 shares

309,745

Datadog Inc.

Common and Preferred Stock 4,214 shares

309,729

12

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

Sarepta Therapeutics Inc.

Common and Preferred Stock 2,341 shares

303,347

Trimble Inc.

Common and Preferred Stock 5,978 shares

302,248

Brown & Brown Inc.

Common and Preferred Stock 5,295 shares

301,656

Mohawk Industries Inc.

Common and Preferred Stock 2,945 shares

301,038

Cabot Corporation

Common and Preferred Stock 4,468 shares

298,641

Cooper Companies Inc.

Common and Preferred Stock 890 shares

294,296

National Retail Properties Inc.

Common and Preferred Stock 6,332 shares

289,752

GlobalFoundries Inc.

Common and Preferred Stock 5,277 shares

284,378

ACV Auctions Inc. Class A

Common and Preferred Stock 34,326 shares

281,816

On Semiconductor Corporation

Common and Preferred Stock 4,496 shares

280,416

Goldman Sachs Group Inc.

Common and Preferred Stock 807 shares

277,108

Dycom Industries Inc.

Common and Preferred Stock 2,883 shares

269,849

Western Alliance Bancorporation

Common and Preferred Stock 4,491 shares

267,484

Momentive Global Inc.

Common and Preferred Stock 37,986 shares

265,902

Carter Inc.

Common and Preferred Stock 3,550 shares

264,866

FTI Consulting Inc.

Common and Preferred Stock 1,664 shares

264,243

Forward Air Corporation

Common and Preferred Stock 2,493 shares

261,491

Tennant Company

Common and Preferred Stock 4,242 shares

261,180

MACOM Technology Solutions Holdings Inc.

Common and Preferred Stock 4,131 shares

260,170

Keysight Technologies Inc.

Common and Preferred Stock 1,472 shares

251,815

Gartner Inc.

Common and Preferred Stock 747 shares

251,097

DoorDash Inc. Class A

Common and Preferred Stock 5,016 shares

244,881

Nvidia Corporation

Common and Preferred Stock 1,661 shares

242,739

ZipRecruiter Inc. Class A

Common and Preferred Stock 14,536 shares

238,681

Huron Consulting Group Inc.

Common and Preferred Stock 3,249 shares

235,877

NRG Energy Inc.

Common and Preferred Stock 7,361 shares

234,227

AerCap Holdings N.V.

Common and Preferred Stock 3,972 shares

231,647

KAR Auction Services Inc.

Common and Preferred Stock 17,586 shares

229,497

Belden Inc.

Common and Preferred Stock 3,117 shares

224,112

BankUnited Inc.

Common and Preferred Stock 6,543 shares

222,266

Sea Limited

Common and Preferred Stock 4,249 shares

221,075

N-Able Technologies International Inc.

Common and Preferred Stock 21,491 shares

220,927

CarGurus Inc. Class A

Common and Preferred Stock 15,757 shares

220,756

National Bank Holdings Corporation Class A

Common and Preferred Stock 5,109 shares

214,936

LPL Financial Holdings Inc.

Common and Preferred Stock 994 shares

214,873

Chemed Corporation

Common and Preferred Stock 416 shares

212,339

UBS Group AG

Common and Preferred Stock 11,334 shares

211,606

Albany International Corporation Class A

Common and Preferred Stock 2,133 shares

210,292

ALLETE Inc.

Common and Preferred Stock 3,257 shares

210,109

Altra Industrial Motion Corporation

Common and Preferred Stock 3,506 shares

209,484

Advanced Energy Industries Inc.

Common and Preferred Stock 2,439 shares

209,217

Certara Inc.

Common and Preferred Stock 12,861 shares

206,676

Magna International Inc.

Common and Preferred Stock 3,673 shares

206,349

KBR, Inc.

Common and Preferred Stock 3,904 shares

206,131

Pfizer Inc.

Common and Preferred Stock 4,022 shares

206,087

Edwards Lifesciences Corporation

Common and Preferred Stock 2,698 shares

201,298

Prosperity Bancshares Inc.

Common and Preferred Stock 2,759 shares

200,524

ASGN Inc.

Common and Preferred Stock 2,428 shares

197,833

Bio-Techne Corporation

Common and Preferred Stock 2,379 shares

197,172

Sally Beauty Holdings Inc.

Common and Preferred Stock 15,576 shares

195,012

Trinet Group Inc.

Common and Preferred Stock 2,830 shares

191,874

13

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

Nasdaq Inc.

Common and Preferred Stock 3,077 shares

188,774

Graphic Packaging Holding Company

Common and Preferred Stock 8,429 shares

187,545

Cardinal Health, Inc.

Common and Preferred Stock 2,414 shares

185,564

Teleflex Inc.

Common and Preferred Stock 742 shares

185,225

Carlisle Companies Inc.

Common and Preferred Stock 784 shares

184,750

Monday.com Limited

Common and Preferred Stock 1,509 shares

184,098

Kirby Corporation

Common and Preferred Stock 2,857 shares

183,848

WillScot Mobile Mini Holdings Corporation

Common and Preferred Stock 4,062 shares

183,481

McKesson Corporation

Common and Preferred Stock 483 shares

181,183

Range Resources Corporation

Common and Preferred Stock 7,153 shares

178,968

Box Inc. Class A

Common and Preferred Stock 5,736 shares

178,562

Smartsheet Inc. Class A

Common and Preferred Stock 4,518 shares

177,828

Matson Inc.

Common and Preferred Stock 2,840 shares

177,528

Shell plc

Common and Preferred Stock 3,111 shares

177,171

Charter Communications, Inc. Class A

Common and Preferred Stock 519 shares

175,993

Copart Inc.

Common and Preferred Stock 2,879 shares

175,302

First American Financial Corporation

Common and Preferred Stock 3,327 shares

174,135

Northern Trust Interest Bearing Cash*

Cash and Cash Equivalents 173,146 units

173,146

Supernus Pharmaceuticals Inc.

Common and Preferred Stock 4,832 shares

172,357

WisdomTree Investments Inc.

Common and Preferred Stock 31,440 shares

171,348

Signature Bank

Common and Preferred Stock 1,480 shares

170,526

Diamondback Energy Inc.

Common and Preferred Stock 1,214 shares

166,051

Dolby Laboratories Inc.

Common and Preferred Stock 2,353 shares

165,981

Graco Inc.

Common and Preferred Stock 2,436 shares

163,845

Airbnb Inc. Class A

Common and Preferred Stock 1,912 shares

163,476

Barnes Group Inc.

Common and Preferred Stock 3,976 shares

162,420

Itron Inc.

Common and Preferred Stock 3,088 shares

156,407

Cohen & Steers Inc.

Common and Preferred Stock 2,421 shares

156,300

Under Armour Inc. Class C

Common and Preferred Stock 17,492 shares

156,029

Woodward Inc.

Common and Preferred Stock 1,596 shares

154,190

AptarGroup Inc.

Common and Preferred Stock 1,399 shares

153,862

Mednax Inc.

Common and Preferred Stock 10,339 shares

153,638

Grand Canyon Education Inc.

Common and Preferred Stock 1,421 shares

150,143

Okta Inc.

Common and Preferred Stock 2,156 shares

147,319

Prestige Consumer Healthcare Inc.

Common and Preferred Stock 2,345 shares

146,797

Oceaneering International Inc.

Common and Preferred Stock 8,251 shares

144,310

Dynatrace Inc.

Common and Preferred Stock 3,731 shares

142,897

Alamos Gold Inc. Class A

Common and Preferred Stock 13,941 shares

140,944

Generac Holdings Inc.

Common and Preferred Stock 1,396 shares

140,521

Veracyte Inc.

Common and Preferred Stock 5,896 shares

139,912

Encompass Health Corporation

Common and Preferred Stock 2,321 shares

138,819

BRP Group Inc. Class A

Common and Preferred Stock 5,498 shares

138,220

NexTier Oilfield Solutions Inc.

Common and Preferred Stock 14,847 shares

137,186

Monro Inc.

Common and Preferred Stock 3,025 shares

136,730

Knowles Corporation

Common and Preferred Stock 8,186 shares

134,414

Markel Corporation Holding Company

Common and Preferred Stock 102 shares

134,384

TreeHouse Foods Inc.

Common and Preferred Stock 2,710 shares

133,820

Consensus Cloud Solutions Inc.

Common and Preferred Stock 2,430 shares

130,637

ACI Worldwide Inc.

Common and Preferred Stock 5,669 shares

130,387

Teledyne Technologies Inc.

Common and Preferred Stock 325 shares

129,971

10X Genomics Inc. Class A

Common and Preferred Stock 3,560 shares

129,726

14

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

Hexcel Corporation

Common and Preferred Stock 2,182 shares

128,411

Tronox Holdings PLC

Common and Preferred Stock 9,262 shares

126,982

John Bean Technologies Corporation

Common and Preferred Stock 1,375 shares

125,579

Matthews International Corporation Class A

Common and Preferred Stock 4,097 shares

124,713

SpringWorks Therapeutics Inc.

Common and Preferred Stock 4,670 shares

121,467

Ciena Corporation

Common and Preferred Stock 2,380 shares

121,332

United Community Bank Blairsville Georgia

Common and Preferred Stock 3,588 shares

121,274

Texas Capital Bancshares Inc.

Common and Preferred Stock 1,997 shares

120,439

Knight-Swift Transportation Holdings Inc. Class A

Common and Preferred Stock 2,296 shares

120,333

Helen Trustoy Limited

Common and Preferred Stock 1,084 shares

120,226

Jacobs Solutions Inc.

Common and Preferred Stock 985 shares

118,269

Hanesbrands Inc.

Common and Preferred Stock 18,223 shares

115,898

Pacific Premier Bancorp Inc.

Common and Preferred Stock 3,669 shares

115,794

Agios Pharmaceuticals Inc.

Common and Preferred Stock 4,120 shares

115,690

Nu Skin Enterprises Inc. Class A

Common and Preferred Stock 2,736 shares

115,350

Nevro Corporation

Common and Preferred Stock 2,855 shares

113,058

C.H. Robinson Worldwide Inc.

Common and Preferred Stock 1,218 shares

111,520

NCR Corporation

Common and Preferred Stock 4,743 shares

111,034

Canada Goose Holdings Inc.

Common and Preferred Stock 6,176 shares

109,995

World Wrestling Entertainment

Common and Preferred Stock 1,603 shares

109,838

8X8 Inc.

Common and Preferred Stock 24,905 shares

107,590

JBG SMITH Properties

Common and Preferred Stock 5,623 shares

106,725

Coherent Corporation

Common and Preferred Stock 3,037 shares

106,599

Cimpress plc

Common and Preferred Stock 3,820 shares

105,470

Sportradar Group

Common and Preferred Stock 10,499 shares

104,570

Legend Biotech Corporation

Common and Preferred Stock 2,069 shares

103,284

Docusign Inc.

Common and Preferred Stock 1,862 shares

103,192

Summit Materials Inc.

Common and Preferred Stock 3,635 shares

103,191

SLR Investment Corporation

Common and Preferred Stock 7,395 shares

102,864

Aspen Technology Inc.

Common and Preferred Stock 472 shares

96,949

CareDx Inc.

Common and Preferred Stock 8,482 shares

96,780

Azekpany Inc.

Common and Preferred Stock 4,640 shares

94,285

Qualtrics International Inc.

Common and Preferred Stock 9,078 shares

94,230

Haemonetics Corporation

Common and Preferred Stock 1,170 shares

92,021

IAA Spinco Inc.

Common and Preferred Stock 2,264 shares

90,560

iShares Russell Mid-Cap ETF

Mutual Fund 1,340 units

90,383

J & J Snack Foods Corporation

Common and Preferred Stock 603 shares

90,275

Mid-American Apartment Communities Inc.

Common and Preferred Stock 573 shares

89,955

PacWest Bancorp

Common and Preferred Stock 3,818 shares

87,623

Sumo Logic Inc.

Common and Preferred Stock 10,650 shares

86,265

Sotera Health Company

Common and Preferred Stock 10,125 shares

84,341

AZZ Inc.

Common and Preferred Stock 2,095 shares

84,219

Arvinas Inc.

Common and Preferred Stock 2,458 shares

84,088

Northwestern Corporation

Common and Preferred Stock 1,400 shares

83,076

Farfetch Limited Class A

Common and Preferred Stock 17,511 shares

82,827

Infinera Corporation

Common and Preferred Stock 12,063 shares

81,305

Silgan Holdings Inc.

Common and Preferred Stock 1,552 shares

80,456

Omnicell Inc.

Common and Preferred Stock 1,541 shares

77,697

Flowserve Corporation

Common and Preferred Stock 2,530 shares

77,620

Wolverine World Wide Inc.

Common and Preferred Stock 7,070 shares

77,275

Middleby Corporation

Common and Preferred Stock 575 shares

76,993

15

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

Tenable Holdings Inc.

Common and Preferred Stock 2,011 shares

76,720

Relay Therapeutics Inc.

Common and Preferred Stock 5,078 shares

75,865

Harsco Corporation

Common and Preferred Stock 11,957 shares

75,210

IPG Photonics Corporation

Common and Preferred Stock 783 shares

74,127

KB Home

Common and Preferred Stock 2,273 shares

72,395

iShares Core S&P Small-Cap ETF

Mutual Fund 754 units

71,359

Doximity Inc.

Common and Preferred Stock 2,092 shares

70,208

C4 Therapeutics Inc.

Common and Preferred Stock 11,878 shares

70,080

Herbalife Nutrition Limited

Common and Preferred Stock 4,671 shares

69,504

Banner Corporation

Common and Preferred Stock 1,089 shares

68,825

Rocket Lab USA Inc.

Common and Preferred Stock 18,208 shares

68,644

1-800-FLOWERS.COM Inc. Class A

Common and Preferred Stock 7,102 shares

67,895

Axogen Inc.

Common and Preferred Stock 6,787 shares

67,734

STAG Industrial Inc.

Common and Preferred Stock 2,083 shares

67,302

WSFS Financial Corporation

Common and Preferred Stock 1,483 shares

67,239

Fox Factory Holding Corporation

Common and Preferred Stock 732 shares

66,780

Coherus BioSciences Inc.

Common and Preferred Stock 8,220 shares

65,102

Albemarle Corporation

Common and Preferred Stock 298 shares

64,624

Sonos Inc.

Common and Preferred Stock 3,759 shares

63,527

Boston Properties Inc.

Common and Preferred Stock 896 shares

60,552

Mercury Systems Inc.

Common and Preferred Stock 1,351 shares

60,444

Designer Brands Inc. Class A

Common and Preferred Stock 6,048 shares

59,149

Heartland Express Inc.

Common and Preferred Stock 3,678 shares

56,421

Berkshire Hills Bancorp Inc.

Common and Preferred Stock 1,723 shares

51,518

CalAmp Corporation

Common and Preferred Stock 10,489 shares

46,991

PetIQ Inc. Class A

Common and Preferred Stock 4,839 shares

44,616

Stevanato Group S.p.A.

Common and Preferred Stock 2,349 shares

42,212

Adeia Inc.

Common and Preferred Stock 4,022 shares

38,129

iShares Russell 2000 ETF

Mutual Fund 215 units

37,487

Rogers Corporation

Common and Preferred Stock 268 shares

31,983

Sterling Check Corporation

Common and Preferred Stock 2,014 shares

31,157

Istar Inc.

Common and Preferred Stock 3,418 shares

26,079

Enhabit Inc.

Common and Preferred Stock 1,160 shares

15,266

eHealth Inc.

Common and Preferred Stock 2,234 shares

10,813

Safehold Inc.

Common and Preferred Stock 261 shares

7,470

Total U.S. Equity Active Asset Class

109,563,201

U.S. Equity Index Asset Class:

NT Collective Russell 3000 Index Fund / Non Lending*

Collective Trust Fund 1,301,755 units

77,492,154

Total U.S. Equity Index Asset Class

77,492,154

International Equity Active Asset Class:

Mawer International Equity Collective Investment Trust Class B*

Collective Trust Fund 1,003,963 units

14,314,907

Polaris Capital Management Collective Investment Trust International Value Collective Fund*

Collective Trust Fund 1,420,400 units

14,170,766

Reliance Trust Institutional Retirement Trust GQG Partners International Equity Fund Series 11 Class C*

Collective Trust Fund 886,595 units

10,887,388

Dodge & Cox International Fund*

Mutual Fund 188,967 units

8,146,368

16

---

Schedule H, line 4i – Schedule of Assets (Held at End of Year) (continued)

Identity of Issue

Description of Investment

Current Value

Wilmington Trust Collective Investment Trust / Jennison International Equity Opportunities CIT Class J*

Collective Trust Fund 1,023,424 units

7,870,129

NT Collective MSCI All Country World Index (ACWI) ex/US Index Fund / Non Lending*

Collective Trust Fund 17,529 units

3,243,062

Total International Equity Active Asset Class

58,632,620

International Equity Index Asset Class:

NT Collective MSCI All Country World Index (ACWI) ex/US Index Fund /Non Lending (Tier J)*

Collective Trust Fund 128,332 units

21,674,049

BlackRock FTSE RAFI Emerging Index Non Lendable Fund F

Collective Trust Fund 1,675 units

8,859

Total International Equity Index Asset Class

21,682,908

Participant Self-Directed Accounts

Various Investments

8,311,430

8,311,430

Notes Receivable from Participants*

Interest Rate 4.25% - 9.25%

15,315,527

15,315,527

Other:

Vanguard Federal Money Market

Cash and Cash Equivalents 27,135 units

27,135

NT Collective Short Term Investment Fund*

Collective Trust Fund 526,957 units

1,368

Total Other

28,503

Grand Total

$

610,319,469

* Indicates party-in-interest

17

---

THE RETIREMENT AND SAVINGS PLAN FOR

AMGEN MANUFACTURING, LIMITED

INDEX TO EXHIBIT

 

Consent of Independent Registered Public Accounting Firm						Exhibit 23.1

18

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

 

The Retirement and Savings Plan for  Amgen Manufacturing, Limited  (Name of Plan)

Date:

June 14, 2023

By:

/s/ PETER H. GRIFFITH

Peter H. Griffith

Deputy Chairman and Chief Financial Officer

Amgen Manufacturing, Limited

19

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 33-47605, 333-144580 and 333-216715) pertaining to The Retirement and Savings Plan for Amgen Manufacturing, Limited of Amgen Inc. of our report dated June 14, 2023, with respect to the financial statements and schedule of The Retirement and Savings Plan for Amgen Manufacturing, Limited included in this Annual Report (Form 11-K) for the year ended December 31, 2022.

/s/ ERNST & YOUNG LLP

Los Angeles, California

June 14, 2023